COVID-19 vaccines Vaccine safety data Main navigation COVID-19 vaccines Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Moderna COVID-19 vaccine AstraZeneca COVID-19 vaccine Novavax COVID-19 vaccine Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox)vaccine AusVaxSafety is conducting active vaccine safety surveillance of the COVID-19 vaccines in use in Australia to ensure their ongoing safety. The COVID-19 vaccines currently being used are Comirnaty (Pfizer), Vaxzevria (AstraZeneca), Spikevax (Moderna) and Nuvaxovid (Novavax). AusVaxSafety is currently reporting safety data on Pfizer, AstraZeneca, Moderna and Novavax COVID-19 vaccines. Data on this page will be updated fortnightly. Reporting update - 9 January 2023 We recently identified duplication of a small number of COVID-19 vaccine safety surveys due to a data processing issue. The issue has been resolved and data this week reflect the true number of respondents, which has resulted in a slightly reduced number of respondents from the previous reporting period. Importantly, this has not changed the adverse event profile reported following COVID-19 vaccination. Latest fortnightly COVID-19 vaccine safety data Click on the tiles below to view AusVaxSafety COVID-19 vaccine safety data for specific population groups. Pfizer COVID-19 vaccine adult formulation View the latest safety data for Pfizer COVID-19 vaccine adult formulation here Pfizer COVID-19 vaccine paediatric formulation (5-11 years) View the latest safety data for Pfizer COVID-19 vaccine paediatric formulation (5-11 years) here Moderna COVID-19 vaccine View the latest Moderna COVID-19 vaccine safety data here AstraZeneca COVID-19 vaccine View the latest AstraZeneca COVID-19 vaccine safety data here Novavax COVID-19 vaccine View the latest Novavax COVID-19 vaccine safety data here Vaccine safety data Main navigation COVID-19 vaccines Pfizer COVID-19 vaccine adult formulation Pfizer COVID-19 vaccine paediatric formulation (5-11 years) Moderna COVID-19 vaccine AstraZeneca COVID-19 vaccine Novavax COVID-19 vaccine Influenza vaccines National Immunisation Program Schedule vaccines Mpox (monkeypox)vaccine News & events All news & events 31 January 2023 | News Short-term adverse event profile of COVID-19 mRNA vaccines in Aussie kids: reassuring data from AusVaxSafety 22 December 2022 | News How common are severe side effects from COVID vaccines? And how are they detected? 12 December 2022 | News AusVaxSafety wins Research Australia Data Innovation Award 27 October 2022 | News JYNNEOS mpox (monkeypox) vaccination – dose 2 better tolerated than dose 1